Applied Molecular Transport Inc. AMTI:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 2:48 PM EST
47.42quote price arrow down-9.72 (-17.01%)
Volume
122,837
52 week range
17.05 - 77.03

...

Loading . . .

KEY STATS

  • Open56.32
  • Day High59.00
  • Day Low46.23
  • Prev Close57.14
  • 52 Week High77.03
  • 52 Week High Date02/22/21
  • 52 Week Low17.05
  • 52 Week Low Date06/09/20
  • Market Cap1.654B
  • Shares Out34.88M
  • 10 Day Average Volume0.13M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-1.65
  • P/E (TTM)-28.80
  • Fwd P/E (NTM)-23.44
  • EBITDA (MRQ)-45.717M
  • ROE (MRQ)-
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.46%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Applied Molecular Transport Inc. News

There is no recent news for this security.

Latest AMTI News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company. The Company is leveraging its technology platform to design and develop a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The Company is building a portfolio of oral product candidates based on its technology platform including its product candidate, AMT-101, an oral GI-selective rhIL-10 that has completed a Phase 1b clinical trial in...
Helen Kim
Chairman
Tahir Mahmood Ph.D.
Chief Executive Officer
Shawn Cross
Chief Financial Officer
Douglas Rich
Chief Technology Officer
Andy Whitney
Vice President
Address
1 Tower Place, Suite 850
South San Francisco, CA
94080
United States